Skip to main content
Equibles

ALLIANCEBERNSTEIN L.P.

Position in DSGN — Design Therapeutics, Inc.

CIK 1109448 NASHVILLE, TN
Back to DSGN Full portfolio

Position in DSGN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$625,538
+$134,822 QoQ
Shares Held
43,230
-6.3% QoQ
Ownership
0.069%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#58
of 136 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in DSGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ALLIANCEBERNSTEIN L.P. holds $5,185,395,108 across 257 Biotechnology names. DSGN ranks #159 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,019,315 $1,499,784,339
2 ARGX
Argenx SE
 395,661 $367,082,405
3 GMAB
Genmab A/S
 8,644,877 $237,474,771
4 REGN
Regeneron Pharmaceuticals, Inc.
 292,338 $182,284,436
5 TECH
BIO-TECHNE Corp
 2,002,026 $141,443,136
6 HALO
Halozyme Therapeutics, Inc.
 1,696,538 $132,788,029
7 KYMR
Kymera Therapeutics, Inc.
 981,521 $112,551,013
8 BBIO
BridgeBio Pharma, Inc.
 1,453,504 $108,256,977

All Filings in DSGN

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $625,538 43,230
2026-03-31 $490,716 46,120
2025-12-31 $432,605 46,120
2025-09-30 $347,283 46,120
2025-06-30 $151,751 45,030
2025-03-31 $162,467 42,090
2024-12-31 $259,695 42,090
2024-09-30 $226,444 42,090
2024-06-30 $141,001 42,090
2024-03-31 $151,125 37,500
2023-12-31 $99,375 37,500
2023-09-30 $97,704 41,400
2023-06-30 $260,820 41,400
2023-03-31 $180,024 31,200
2022-12-31 $283,176 27,600
2022-09-30 $354,464 21,200
2022-06-30 $196,000 14,000